Coherus Confirms Filing Plans For Ranibizumab And Bevacizumab

Both Biosimilar Filings Have Experienced Delays

 
• By Dean Rudge
FDAEntrance_1200x675
Coherus expects ranibizumab will be filed with the FDA midway through 2021 • Source: Shutterstock

More from Biosimilars

More from Products